Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06550804 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Testing a Real-time Electronic Antiretroviral Adherence Monitoring Intervention

Study acronym: A-TEAM
StatusActive, Not Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Feb 2026 → Mar 2027
See other at-risk trials from University of Illinois at Chicago

Record History

  1. Primary completion pushed from Feb 2026 to Mar 2027 Enrollment closed, study ongoing · Completion pushed from Jul 2026 to Mar 2027 · Site details revisedv3 Show 3 more changesShow less
    • Enrollment closed, study ongoing
    • Completion pushed from Jul 2026 to Mar 2027
    • Site details revised
  2. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Oct 2024 to Oct 1, 2024v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Oct 2024 to Oct 1, 2024
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The investigators propose using an electronic adherence device that is basically a pill container that can alert when it is not opened at a scheduled time. The investigators will use this device to alert the medication user at the time when medication is supposed to be taken if the device did not get opened and a pre-identified social support person or case manager when 2 or 7 consecutive days of nonadherence are detected, respectively. The investigators call our approach "A-Team" (Antiretroviral Therapy Electronic Adherence Monitoring). The aims of this application are to determine the acceptability and feasibility of real-time adherence monitoring in support persons and case managers of African American Men who have sex with Men and to test this approach for these men in a 6-month randomized controlled trial among 54 of these men living with HIV and measure ART adherence and viral suppression (the primary outcome).
Trial Details
NCT Number NCT06550804
Lead Sponsor University of Illinois at Chicago
Collaborators: Massachusetts General Hospital
Conditions HIV Infections, Adherence, Medication
Enrollment 126 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov